From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza. [PDF]
Sun Y +4 more
europepmc +1 more source
Strain Matching of Seasonal Influenza Vaccines and Emergence of Neuraminidase Inhibitor Resistance in China from 2015 to 2025. [PDF]
He P +6 more
europepmc +1 more source
Separating the effects of temperature and absorbed X-ray dose on unit-cell volume. [PDF]
Southworth-Davies RJ +5 more
europepmc +1 more source
H1N1 seasonal surge in India, 2026: Emerging public health threat and evidence based preventive strategies. [PDF]
Choudhary OP, Choudhary P.
europepmc +1 more source
A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses. [PDF]
Liu D +11 more
europepmc +1 more source
A nanoemulsion-adjuvanted trivalent neuraminidase vaccine confers cross-protection against divergent influenza viruses. [PDF]
Bai J +7 more
europepmc +1 more source
Novel Phloroglucinol Derivatives as Neuraminidase Inhibitors Identified From Humulus lupulus L. Extract by At-Line Nanofractionation Platform. [PDF]
Chen Z +7 more
europepmc +1 more source
Genomic Characterization of Influenza B Victoria Lineage Viruses Circulating in Saudi Arabia During the 2024-2025 Season. [PDF]
Alzahrani N +9 more
europepmc +1 more source
<i>Arbutus andrachne</i> Extracts Exhibit In Vitro Neuraminidase (N9) Inhibitory Activity: A Potential Herbal Strategy Against Avian Influenza. [PDF]
Abuhammad A +7 more
europepmc +1 more source
Emergence and Genomic Characterisation of Influenza Virus A(H3N2) Subclade K in Saudi Arabia: Dominant Circulation With Fixed HA1 Substitutions and High-Frequency HA-NA Clade Association, 2025-2026. [PDF]
Naeem A +4 more
europepmc +1 more source

